中国胰腺神经内分泌肿瘤诊疗指南 (2020)

2021-06-21 中华医学会外科学分会胰腺外科学组 协和医学杂志

胰腺神经内分泌肿瘤具有高度异质性,患者的临床管理存在一定难度。为了应对这一挑战,中华医学会外 科学分会胰腺外科学组牵头成立了由肿瘤外科、消化内科、肿瘤内科、内分泌科、影像科、病理科、核医学科等多领域

中文标题:

中国胰腺神经内分泌肿瘤诊疗指南 (2020)

发布日期:

2021-06-21

简要介绍:

胰腺神经内分泌肿瘤具有高度异质性,患者的临床管理存在一定难度。为了应对这一挑战,中华医学会外 科学分会胰腺外科学组牵头成立了由肿瘤外科、消化内科、肿瘤内科、内分泌科、影像科、病理科、核医学科等多领域 学者组成的专家委员会。该委员会回顾了与胰腺神经内分泌肿瘤诊断和治疗相关的重要问题,并基于循证医学证据提出 了相应的诊疗建议,以期进一步改进中国胰腺神经内分泌肿瘤患者的诊疗流程。

下载附件:

(因为版权问题,不支持下载)

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206077, encodeId=9a5712060e79c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqCoDMNz4hWhaHjOhjBibyibib5RqwGBz8AfNlDoVWV7BpLc7UDz0JneHUJAxG6fa1XvyIw7OdOtndVw/132, createdBy=50c22041566, createdName=Nature12, createdTime=Sat Mar 26 10:59:04 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203922, encodeId=ff741203922af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4e36405798, createdName=ms8000001399943020, createdTime=Fri Mar 18 23:04:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183399, encodeId=a3451183399b3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45fb6271004, createdName=31950_1162, createdTime=Tue Jan 11 23:38:49 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178887, encodeId=f20011e8887b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Dec 30 16:01:44 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067687, encodeId=c483106e687cb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Sat Nov 06 23:06:33 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2022-03-26 Nature12

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206077, encodeId=9a5712060e79c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqCoDMNz4hWhaHjOhjBibyibib5RqwGBz8AfNlDoVWV7BpLc7UDz0JneHUJAxG6fa1XvyIw7OdOtndVw/132, createdBy=50c22041566, createdName=Nature12, createdTime=Sat Mar 26 10:59:04 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203922, encodeId=ff741203922af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4e36405798, createdName=ms8000001399943020, createdTime=Fri Mar 18 23:04:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183399, encodeId=a3451183399b3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45fb6271004, createdName=31950_1162, createdTime=Tue Jan 11 23:38:49 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178887, encodeId=f20011e8887b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Dec 30 16:01:44 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067687, encodeId=c483106e687cb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Sat Nov 06 23:06:33 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2022-03-18 ms8000001399943020

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206077, encodeId=9a5712060e79c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqCoDMNz4hWhaHjOhjBibyibib5RqwGBz8AfNlDoVWV7BpLc7UDz0JneHUJAxG6fa1XvyIw7OdOtndVw/132, createdBy=50c22041566, createdName=Nature12, createdTime=Sat Mar 26 10:59:04 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203922, encodeId=ff741203922af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4e36405798, createdName=ms8000001399943020, createdTime=Fri Mar 18 23:04:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183399, encodeId=a3451183399b3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45fb6271004, createdName=31950_1162, createdTime=Tue Jan 11 23:38:49 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178887, encodeId=f20011e8887b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Dec 30 16:01:44 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067687, encodeId=c483106e687cb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Sat Nov 06 23:06:33 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2022-01-11 31950_1162

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1206077, encodeId=9a5712060e79c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqCoDMNz4hWhaHjOhjBibyibib5RqwGBz8AfNlDoVWV7BpLc7UDz0JneHUJAxG6fa1XvyIw7OdOtndVw/132, createdBy=50c22041566, createdName=Nature12, createdTime=Sat Mar 26 10:59:04 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203922, encodeId=ff741203922af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4e36405798, createdName=ms8000001399943020, createdTime=Fri Mar 18 23:04:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183399, encodeId=a3451183399b3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45fb6271004, createdName=31950_1162, createdTime=Tue Jan 11 23:38:49 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178887, encodeId=f20011e8887b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Dec 30 16:01:44 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067687, encodeId=c483106e687cb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Sat Nov 06 23:06:33 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-12-30 杨小屁

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1206077, encodeId=9a5712060e79c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqCoDMNz4hWhaHjOhjBibyibib5RqwGBz8AfNlDoVWV7BpLc7UDz0JneHUJAxG6fa1XvyIw7OdOtndVw/132, createdBy=50c22041566, createdName=Nature12, createdTime=Sat Mar 26 10:59:04 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203922, encodeId=ff741203922af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4e36405798, createdName=ms8000001399943020, createdTime=Fri Mar 18 23:04:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183399, encodeId=a3451183399b3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45fb6271004, createdName=31950_1162, createdTime=Tue Jan 11 23:38:49 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178887, encodeId=f20011e8887b6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Dec 30 16:01:44 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067687, encodeId=c483106e687cb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Sat Nov 06 23:06:33 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-11-06 gghhzb

    学习了

    0

拓展阅读

胰腺囊性疾病诊治指南2015

中华医学会外科学分会胰腺外科学组 · 2016-04-25

2015年美国消化内镜学会指南:内镜在胰腺实性肿瘤患者评估和管理中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2016-06-08

2016年ASGE指南:内镜检查在炎性胰腺液体积聚诊治中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2016-01-12

内镜在胰腺良性疾病中的应用相关指南解读

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2016-06-08

2015年ASGE指南:内镜在胰腺实体肿瘤患者评估和管理中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2016-06-08